{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:37:38Z","timestamp":1786649858299,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T00:00:00Z","timestamp":1418688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1208\/s12249-014-0258-9","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T22:58:55Z","timestamp":1418684335000},"page":"692-703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Intraoral Film Containing Insulin-Phospholipid Microemulsion: Formulation and In Vivo Hypoglycemic Activity Study"],"prefix":"10.1208","volume":"16","author":[{"given":"Heni","family":"Rachmawati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard Manuel","family":"Haryadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusnandar","family":"Anggadiredja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veinardi","family":"Suendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,16]]},"reference":[{"key":"258_CR1","unstructured":"Triplitt CL, Reasner CA, Isle WL. Diabetes mellitus, 1205\u20131241 in book: pharmacotherapy: a pathophysiologic approach. 7th ed. New York: The McGraw-Hill Companies, Inc; 2008. p. 2597."},{"issue":"3","key":"258_CR2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/193229680900300323","volume":"3","author":"L Heineman","year":"2009","unstructured":"Heineman L, Jacques Y. Oral insulin and buccal insulin: a critical reappraisal. J Diabetes Sci Tech. 2009;3(3):568\u201383.","journal-title":"J Diabetes Sci Tech"},{"key":"258_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1742-1241.2010.02577.x","volume":"65","author":"L Heinemann","year":"2011","unstructured":"Heinemann L. New ways of insulin delivery. Int J Clin Pract. 2011;65:31\u201346.","journal-title":"Int J Clin Pract"},{"key":"258_CR4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1262-3636(06)72804-X","volume":"32","author":"V Lassmann-Vague","year":"2006","unstructured":"Lassmann-Vague V, Racca D. Alternatives routes of insulin delivery. Diabetes Metab. 2006;32:513\u201322.","journal-title":"Diabetes Metab"},{"key":"258_CR5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2012.03.056","volume":"440","author":"MR Rekha","year":"2013","unstructured":"Rekha MR, Sharma CP. Oral delivery of therapeutic protein\/peptide for diabetes\u2014future perspectives. Int J Pharm. 2013;440:48\u201352.","journal-title":"Int J Pharm"},{"issue":"2","key":"258_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1463-1326.2009.01127.x","volume":"12","author":"P Pozzilli","year":"2010","unstructured":"Pozzilli P, Raskin P, Parkin CG. Review of clinical trials: update on oral insulin spray formulation. Diabetes Obes Metab. 2010;12(2):1\u20138.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"258_CR7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1463-1326.2009.01150.x","volume":"12","author":"H Iyer","year":"2010","unstructured":"Iyer H, Khedkar A, Verma M. Oral insulin\u2014a review of current status. Diabetes Obes Metab. 2010;12(3):179\u201385.","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"258_CR8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1586\/erd.09.43","volume":"6","author":"RM Ramesan","year":"2009","unstructured":"Ramesan RM, Sharma CP. Challenges and advances in nanoparticle-based oral insulin delivery. Exp Rev Med Devices. 2009;6(6):665\u201376.","journal-title":"Exp Rev Med Devices"},{"key":"258_CR9","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.addr.2007.08.019","volume":"59","author":"ES Khafagy","year":"2007","unstructured":"Khafagy ES, Morishita M, Onuki Y, Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Del. 2007;59:1521\u201346.","journal-title":"Adv Drug Del"},{"key":"258_CR10","first-page":"14","volume-title":"Therapeutic peptides and proteins formulation, processing, and delivery systems","year":"2006","unstructured":"Banga AK, editor. Therapeutic peptides and proteins formulation, processing, and delivery systems. 2nd ed. Boca Raton: Taylor & Francis; 2006. p. 14\u201383.","edition":"2"},{"key":"258_CR11","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1016\/j.biomaterials.2011.08.087","volume":"32","author":"MC Chen","year":"2011","unstructured":"Chen MC, Sonaje K, Chen KJ, Sung HW. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. Biomat. 2011;32:9826\u201338.","journal-title":"Biomat"},{"key":"258_CR12","first-page":"12","volume":"8","author":"XY Li","year":"2013","unstructured":"Li XY, Qi JP, Xie YC, Zhang X, Hu SW, Xu Y, et al. Microemulsions coated with alginate\/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats. Int J Nanomedicine. 2013;8:12\u201321.","journal-title":"Int J Nanomedicine"},{"issue":"2\u20133","key":"258_CR13","first-page":"7","volume":"362","author":"SVR Rao","year":"2008","unstructured":"Rao SVR, Shao J. Self-microemulsion drug delivery systems (SNEDDS) for oral delivery of protein drugs 1: formulation development. Int J Pharm. 2008;362(2\u20133):7\u20138.","journal-title":"Int J Pharm"},{"key":"258_CR14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-physchem-032210-103436","volume":"6","author":"MM Fryd","year":"2012","unstructured":"Fryd MM, Mason TG. Advanced microemulsions. Annu Rev Phys Chem. 2012;6:493\u2013518.","journal-title":"Annu Rev Phys Chem"},{"key":"258_CR15","doi-asserted-by":"crossref","unstructured":"Sadtler V, Galindo-Alvarez JM, and Marie-B\u00e9gu\u00e9 E. Low energy emulsification methods for nanoparticles synthesis, 509\u2013524 dalam Hashim, A.A. The delivery of nanoparticles. InTech, Rijeka-Croatia. 2012:p. 540.","DOI":"10.5772\/35087"},{"issue":"6","key":"258_CR16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1365-2710.2000.00306.x","volume":"25","author":"ST Dogru","year":"2000","unstructured":"Dogru ST, Calis S, Oner F. Oral multiple W\/O\/W emulsion formulation of a peptide salmon calcitonin: in vitro-in vivo evaluation. J Clin Pharm Ther. 2000;25(6):435\u201343.","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"258_CR17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/02652048.2012.665091","volume":"29","author":"N Celebi","year":"2012","unstructured":"Celebi N, Yetkin G, Ozer C, Can A, G\u00f6k\u00e7ora N. Evaluation of microemulsion and liposomes as carriers for oral delivery of transforming growth factor alpha in rats. J Microencapsul. 2012;29(6):539\u201348.","journal-title":"J Microencapsul"},{"issue":"1","key":"258_CR18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10717540500313109","volume":"13","author":"A \u00c7ilek","year":"2005","unstructured":"\u00c7ilek A, \u00c7elebi N, Tirnaksiz F. Lecithin-based microemulsion of a peptide for oral administration: preparation, characterization, and physical stability of the formulation. Drug Deliv. 2005;13(1):19\u201324.","journal-title":"Drug Deliv"},{"issue":"1","key":"258_CR19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2005.04.016","volume":"298","author":"A \u00c7ilek","year":"2006","unstructured":"\u00c7ilek A, \u00c7elebi N, Tirnaksiz F, Tay A. A lecithin-based microemulsion of Rh-insulin with aprotinin for oral administration: investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats. Int J Pharm. 2006;298(1):176\u201385.","journal-title":"Int J Pharm"},{"key":"258_CR20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0378-5173(02)00674-9","volume":"252","author":"E Toorisaka","year":"2003","unstructured":"Toorisaka E, Ono H, Arimori K, Kamiya N, Goto M. Hypoglycemic effect of surfactant-coated insulin solubilized in a novel solid-in-oil-in-oil water (S\/O\/W) emulsion. Int J Pharm. 2003;252:271\u20134.","journal-title":"Int J Pharm"},{"key":"258_CR21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0168-3659(00)00326-6","volume":"69","author":"T Morita","year":"2000","unstructured":"Morita T, Sakamura Y, Horikir Y, Suzuki T, Yoshino H. Protein encapsulation into biodegradable microspheres by a novel S\/O\/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvant. J Con Rel. 2000;69:435\u201344.","journal-title":"J Con Rel"},{"issue":"1","key":"258_CR22","first-page":"1","volume":"5","author":"H Rachmawati","year":"2014","unstructured":"Rachmawati H, Haryadi DM. The influence of polymer structure on the physical characteristic of intraoral film containing BSA-loaded nanoemulsion. J Nanomed Nanotechnol. 2014;5(1):1\u20136.","journal-title":"J Nanomed Nanotechnol"},{"issue":"4","key":"258_CR23","first-page":"1303","volume":"14","author":"H Rachmawati","year":"2013","unstructured":"Rachmawati H, Edityaningrum CA, Mauluddin R. Molecular inclusion complex of curcumin-\u03b2-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gel. Am Assoc Pharm Scie Pharm Sci Tech. 2013;14(4):1303\u201312.","journal-title":"Am Assoc Pharm Scie Pharm Sci Tech"},{"key":"258_CR24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2006.05.013","volume":"114","author":"FD Cui","year":"2006","unstructured":"Cui FD, Shi K, Zhang LQ, Tao AJ, Kawashima Y. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Con Rel. 2006;114:242\u201350.","journal-title":"J Con Rel"},{"key":"258_CR25","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.biomaterials.2011.10.072","volume":"3","author":"Q Peng","year":"2012","unstructured":"Peng Q, Zhang ZR, Gong T, Chen GQ, Sun X. A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles. Biomat. 2012;3:1583\u20138.","journal-title":"Biomat"},{"key":"258_CR26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/psc.2423","volume":"18","author":"CP Zhou","year":"2012","unstructured":"Zhou CP, Xia XJ, Liu YL, Li L. The preparation of a complex of insulin-phospholipids and their interaction mechanism. J Pept Sci. 2012;18:541\u20138.","journal-title":"J Pept Sci"},{"key":"258_CR27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.colsurfb.2011.10.005","volume":"90","author":"H Pawar","year":"2012","unstructured":"Pawar H, Douromumis D, Boateng JS. Preparation and optimization of PMAA-chitosan-PEG nanoparticle for oral drug delivery. Coll Surf B. 2012;90:102\u20138.","journal-title":"Coll Surf B"},{"key":"258_CR28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2006.01.022","volume":"314","author":"A Saupe","year":"2006","unstructured":"Saupe A, Gordon K, Rades T. Structural investigations on microemulsions, solid lipid nanoparticles, and nanostructured lipid carriers by cryo-field emission scanning electron microscopy, and Raman spectroscopy. Int J Pharm. 2006;314:56\u201362.","journal-title":"Int J Pharm"},{"key":"258_CR29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ab.2004.06.013","volume":"332","author":"C Ortiz","year":"2004","unstructured":"Ortiz C, Zhang DM, Xie Y, Davisson JV, dam Ben-Amotz D. Identification of insulin variants using Raman spectroscopy. Anal Biochem. 2004;332:245\u201352.","journal-title":"Anal Biochem"},{"key":"258_CR30","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.2042-7158.2011.01338.x","volume":"63","author":"SLM Tay","year":"2011","unstructured":"Tay SLM, Heng PWS, Chan LW. An investigation of the chick chorioallantoic membrane as an alternative model to various biological tissues for permeation studies. J Pharm Pharmacol. 2011;63:1283\u20139.","journal-title":"J Pharm Pharmacol"},{"key":"258_CR31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-5173(98)00064-7","volume":"170","author":"JM Haigh","year":"1998","unstructured":"Haigh JM, Beyssac E, Chanet L, Aiache JM. In vitro permeation of progesterone from a gel through shed skin of three different snake species. Int J Pharm. 1998;170:151\u20136.","journal-title":"Int J Pharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-014-0258-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-014-0258-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-014-0258-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T13:18:30Z","timestamp":1566134310000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-014-0258-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,16]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["258"],"URL":"https:\/\/doi.org\/10.1208\/s12249-014-0258-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,16]]}}}